The global ePharmacy market sales is expected to have risen at a 14.3% compound annual growth rate from US$ 81.5 billion in 2022 to US$ 351.9 billion by the end of 2033. As e-commerce and internet use become more common, there is an increase in demand for mail-order pharmaceuticals. A large number of online pharmacies …
Category Archives: Healthcare Trends
Acetaminophen Market Skyrockets to a Whopping US$ 15.2 Billion Valuation by 2033-FMI Projection
With a US$ 9.8 billion market valuation as of 2022, the worldwide acetaminophen market sales stands tall in a pharmaceutical landscape characterised by durability and evolution. In addition to describing its current position, a recent analysis by Future Market Insights projects an excellent trajectory with a Compound Annual Growth Rate (CAGR) of 4.2%. By 2033, …
Global Oocyte Retrieval Needles Industry is anticipated to achieve remarkable growth, surpassing an estimated US$ 724.6 million by 2033, according to FMI
The global oocyte retrieval needles industry demand is poised to witness remarkable growth, with projections indicating a substantial leap from its 2023 valuation of US$ 359.1 million to an estimated worth of US$ 724.6 million by 2033. This growth trajectory signifies an impressive Compound Annual Growth Rate (CAGR) of 7.3% throughout the forecast period. The …
Global Point-of-Care Food Sensitivity Testing Industry is expected to experience substantial growth, surpassing US$ 516.8 Million by 2033, according to FMI
In 2023, the global point-of-care food sensitivity testing industry demand attained a significant milestone, surging to a valuation of US$ 159.3 million. Projections indicate an impressive trajectory, with estimations foreseeing the market to ascend to a remarkable US$ 516.8 million by 2033. This growth trend is set to maintain a robust 12.5% compound annual growth …
Global Pediatric Home Healthcare Industry is expected to witness substantial growth, with a potential value of US$ 197 Billion by 2033, according to FMI
The global pediatric home healthcare industry demand is worth US$ 38 Billion as of now and is expected to reach US$ 197 Billion by the year 2033 at a whopping CAGR of 16.3% between 2023 and 2033. Life-sustaining pediatric home healthcare services are found to have reduced the hospital stays for the ones with respiratory, …
Global Head and Neck Cancer Therapeutics Industry with a projected 12.6% CAGR, is set to achieve US$ 5.19 Billion by 2033, according to FMI
The global head and neck cancer (HNC) therapeutics industry size is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, is expected to surpass an impressive valuation of US$ 5.19 Billion by 2033 with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head …
Global PD1 Non-Small Cell Lung Cancer Treatment Industry is anticipated to witness an impressive CAGR of 8.51%, reaching a staggering US$ 61 Billion by 2033
According to a recent study published by Future Market Insights, the global PD1 non-small cell lung cancer treatment industry size is slated to reach a valuation of US$ 26.96 Billion in 2023, and will further increase to US$ 61 Billion, registering a CAGR of 8.51% from 2023 to 2033. Rising prevalence of non-small cell lung …
Global Drug Discovery Informatics Industry, guided by the data-centric evolution reshaping drug discovery, is projected to pursue a US$ 12.5 Billion by 2033 | FMI
According to a recently published analytical report by Future Market Insights, the global drug discovery informatics industry demand is expected to generate US$ 2.9 billion in sales by 2022. The market is predicted to reach a valuation of US$ 12.5 billion by 2033 with a CAGR of 14.4% from 2023 to 2033. With a CAGR …
Global Prinzmetal Angina Therapeutics Industry is poised to achieve a staggering US$ 17.2 Billion by 2033 as per the FMI Report
The global prinzmetal angina therapeutics industry demand is expected to surpass an impressive valuation of US$ 10.7 Billion in 2023 and is projected to reach US$ 17.2 Billion by 2033, trailing a CAGR of 4.85%. The development of biosimilars and biobetters, growth in diabetic and hypertension population due to unhealthy lifestyle and rise in consumption of …
Global Isovaleric Acidemia Treatment Industry is expected to potentially attain US$ 1,125.15 Million by 2033, according to FMI
The global isovaleric acidemia treatment industry demand is expected to be valued at US$ 652.28 Million in 2023 and is projected to reach US$ 1,125.15 Million by 2033, trailing a CAGR of 5.6%. Mass spectrometry development coupled with chromatography has advanced the reliability and efficiency of Isovaleric Acidemia profiling and shows the key structures in …